Invention Grant
![Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders](/docs/US/2018-03-13/US09914732B2/abs.jpg.600x600.jpg)
- Patent Title: Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
-
Application No.: US15113529Application Date: 2015-01-26
-
Publication No.: US09914732B2Publication Date: 2018-03-13
- Inventor: Yansong Wang , Felix Hausch , Matthias Bischoff , Sebastian Pomplun
- Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
- Applicant Address: DE Munich
- Assignee: Max-Planck-Gesellschaft zur Forderung der Wissensc haften e.V.
- Current Assignee: Max-Planck-Gesellschaft zur Forderung der Wissensc haften e.V.
- Current Assignee Address: DE Munich
- Agency: Amin, Turocy & Watson LLP
- Priority: EP14152567 20140124; EP14186483 20140925
- International Application: PCT/EP2015/000176 WO 20150126
- International Announcement: WO2015/110271 WO 20150730
- Main IPC: C07D471/08
- IPC: C07D471/08 ; A61K31/551 ; A61K31/635 ; A61K45/06 ; C07D211/60 ; C07D303/36
![Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders](/abs-image/US/2018/03/13/US09914732B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to diazabicyclo[4.3.1]decane derivatives, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said diazabicyclo[4.3.1]decane derivatives can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.
Public/Granted literature
- US20170002003A1 DIAZABICYCLO[4.3.1]DECANE DERIVATIVES FOR TREATMENT OF PSYCHIATRIC DISORDERS Public/Granted day:2017-01-05
Information query
